Denmark‘s economy is heading for slower growth as the pharmaceutical boom led by Novo Nordisk A/S loses steam and the industry settles into a pace more in line with the rest of the economy, the country’s financial watchdog said.
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.